Comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders".

Favresse, Julien;Gruson, Damien;Gheldof, Damien
(2019) Molecular Genetics and Metabolism Reports — Vol. 21, p. 100506 (2019)

Files

2019_Favresse_Mol_Genet_Metab_Rep.pdf
  • Open Access
  • Adobe PDF
  • 341.86 KB
Download

Details

Authors
  • Favresse, JulienUCLouvain
    Author
  • Gruson, DamienUCLouvain
    Author
  • Gheldof, Damien
    Author
Abstract
To the Editor, We read with interest the publication of Barry Wolf published in the latest issue of Molecular Genetics and Metabolism [1]. Biotin interference has become a major problem with some laboratory assays and harmful clinical consequences have been reported. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Favresse, J., Gruson, D., & Gheldof, D. (2019). Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”. Molecular Genetics and Metabolism Reports, 21, 100506. https://doi.org/10.1016/j.ymgmr.2019.100506 (Original work published 2019)